T1	SNP 0 13	Polymorphisms
T2	Entity 21 25	UBC9
T3	Entity 30 35	PIAS3
T4	Association 91 95	risk
E1	Association:T4 bc:T5 snp_int:T1
T5	Cancer 77 90	breast cancer
R1	SNP_coupled_gene Arg1:T1 Arg2:T2	
R2	SNP_coupled_gene Arg1:T1 Arg2:T3	
T6	Patho_physiology 49 72	SUMO-conjugating system
E2	Patho_physiology:T6 Agent:T1
T7	Patho_physiology 98 109	SUMOylation
E3	Patho_physiology:T7 
R3	Equiv Arg1:E3 Arg2:E2	
T8	Patho_physiology 269 282	tumorigenesis
E4	Patho_physiology:T8 
R4	Member Arg1:E2 Arg2:E4	
T9	SNP 413 422	variation
T10	Entity 430 434	UBC9
R5	SNP_coupled_gene Arg1:T9 Arg2:T10	
T11	Organic_inorganic_molecules_affected 453 476	SUMO-conjugating enzyme
E5	Organic_inorganic_molecules_affected:T11 Agent:T9
T12	Spec 477 480	may
T13	Cell_types_tissues_affected 492 497	grade
E6	Cell_types_tissues_affected:T13 Theme:T14 Agent:T9
T14	Entity 501 514	breast tumors
R6	Speculation_marker Arg1:E6 Arg2:T12	
T15	SNP 654 668	one coding SNP
T16	Entity 672 677	PIAS3
R7	SNP_coupled_gene Arg1:T15 Arg2:T16	
T17	SNP 682 696	seven tag SNPs
T18	Entity 700 704	UBC9
R8	SNP_coupled_gene Arg1:T17 Arg2:T18	
T19	Association 1096 1108	associations
E7	Association:T19 snp_int:T20 bc:T22
T20	SNP 1112 1116;1122 1135	four polymorphisms
T21	Entity 1117 1121	UBC9
R9	SNP_coupled_gene Arg1:T20 Arg2:T21	
T22	Cancer 1149 1163	grade 1 tumors
A1	Cancer_Type T22 Other
R10	Member Arg1:T17 Arg2:T20	
A2	SNP_Class T17 tSNP
A3	SNP_Class T20 tSNP
T23	Association 1251 1255	risk
E8	Association:T23 bc:T22
T24	SNP 1273 1282	rs7187167
R11	Member Arg1:T20 Arg2:T24	
T25	Level 1289 1308	dominant penetrance
R12	Level_marker Arg1:E8 Arg2:T25	
A4	Level E8 High
T26	Entity 1310 1315	Women
R13	Population_assignment Arg1:T24 Arg2:T26	
T27	Entity 1329 1340	rare allele
T28	SNP 1273 1282	rs7187167
R14	SNP_allele Arg1:T28 Arg2:T27	
R15	Population_assignment Arg1:T28 Arg2:T26	
T29	Effect_Type 1351 1360	increased
T30	Association 1361 1365	risk
E9	Association:T30 snp_int:T28 bc:T31
R16	Effect_type_marker Arg1:E9 Arg2:T29	
A5	Effect_Type E9 Increase
T31	Cancer 1369 1383	grade 1 tumors
T32	Entity 1398 1416	common homozygotes
T33	SNP 1273 1282	rs7187167
R17	Genotype Arg1:T33 Arg2:T32	
E10	Association:T30 bc:T31 snp_int:T33
R18	Population_assignment Arg1:T33 Arg2:T26	
T34	Association 1446 1457	This effect
E11	Association:T34 bc:T31 snp_int:T39
T35	Level 1473 1481	stronger
R19	Level_marker Arg1:E11 Arg2:T35	
A6	Level E11 High
T36	Entity 1485 1490	women
T37	Entity 1498 1522;1534 1540	family history of breast cancer
T38	Entity 1498 1515;1526 1540	family history of ovarian cancer
T39	SNP 1273 1282	rs7187167
R20	Population_assignment Arg1:T39 Arg2:T36	
R21	Risk_Factor Arg1:T39 Arg2:T38	
R22	Risk_Factor Arg1:T39 Arg2:T37	
T40	SNP 1701 1718	genetic variation
T41	Entity 1722 1726	UBC9
R23	SNP_coupled_gene Arg1:T40 Arg2:T41	
T42	Spec 1727 1730	may
T43	Association 1731 1737	affect
E12	Association:T43 bc:T44 snp_int:T40
T44	Cancer 1750 1771	grade 1 breast tumors
A7	Cancer_Type T44 Other
R24	Speculation_marker Arg1:E12 Arg2:T42	
R25	Member Arg1:T20 Arg2:T39	
R26	Member Arg1:T20 Arg2:T33	
R27	Member Arg1:T20 Arg2:T28	
R28	Equiv Arg1:T20 Arg2:T40	
T45	SNP 1556 1569	polymorphisms
T46	Entity 1575 1623	300-kb region around the genotyped polymorphisms
R29	SNP_location Arg1:T45 Arg2:T46	
T47	SNP 1600 1623	genotyped polymorphisms
R30	Equiv Arg1:T47 Arg2:T20	
R31	SNP_coupled_gene Arg1:T45 Arg2:T41	
T48	Neg 1635 1637	no
T49	Level 1652 1660	stronger
T50	Association 1661 1673	associations
E13	Association:T50 snp_int:T45 bc:T44
R32	Level_marker Arg1:E13 Arg2:T49	
R33	Negation_marker Arg1:E13 Arg2:T48	
A8	Level E13 High
